CD44 Predisposes the Epileptogenesis of Cortical Tubers by Regulating CASK and Acts as a Potential Biomarker to Identify Epileptogenic Tuber in Tuberous Sclerosis Complex
CNS Neuroscience & Therapeutics · 2026-11 · 32 (11)
DOI: 10.1002/cns.71262 ↗Abstract
ABSTRACT Background Tuberous sclerosis complex (TSC) is characterized by developmental delay and intractable epilepsy, with multiple cortical tubers in the brain. However, the mechanism underlying epileptogenesis within these tubers remains unclear. Methods RNA sequencing (RNA‐seq) analysis of resected human cortical tubers identified differential CD44 expression as a potential contributor to TSC epilepsy. By analyzing clinical characteristics, resected brain tissues, 18 F‐fludeoxyglucose PET images, cultured cortical neurons, and neocortical seizure animal models, the effect of CD44 on the epileptogenesis of cortical tubers was investigated. Results Increased CD44 expression was found in human Epi tubers compared with non‐Epi tubers and closely correlated with the clinical characteristics of Epi tubers. CD44 activation increased neocortical seizure susceptibility and aggravated cortical pyramidal neuronal excitatory/inhibitory (E/I) imbalance. CASK was selected as the downstream target of CD44 using RNA‐seq. Anti‐CD44 monoclonal antibodies rescued the E/I imbalance in resected Epi tubers, and CD44 activation rescued the decreased firing frequency and increased action potential threshold induced by CASK inhibition. The CD44–CASK pathway exhibited diagnostic potential for identifying Epi tubers and predicting surgical outcomes via ROC analysis. Conclusion CD44 activation predisposes cortical tubers to epileptogenesis, and could be a potential biomarker for identifying Epi tubers and predicting surgical outcomes in TSC patients.
EUVIMED